Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Third top Pentagon aide Collin Carroll on administrative leave over leaks probe

by admin April 17, 2025
April 17, 2025
Third top Pentagon aide Collin Carroll on administrative leave over leaks probe

A third high-level Pentagon staffer has been placed on administrative leave in two days as part of a probe into media leaks.

Colin Carroll, chief of staff to Deputy Secretary Stephen Feinberg, was escorted out of the building on Wednesday, following Dan Caldwell, senior advisor to Secretary Pete Hegseth, and Darin Selnick, deputy chief of staff to Hegseth. 

‘We can confirm that Mr. Carroll has been placed on administrative leave pending investigation. We have nothing additional to provide at this time,’ a defense official told Fox News Digital. 

Carroll did not immediately respond to a request for comment. 

The Pentagon has not provided specifics about what the three officials are accused of leaking. 

Last month Defense Department (DOD) announced it would launch a probe into ‘recent unauthorized disclosures of national security information’ and might employ the use of polygraphs to determine the source of the leaks. 

‘The use of polygraphs in the execution of this investigation will be in accordance with applicable law and policy,’ DOD Chief of Staff Joe Kasper wrote in a memo. ‘This investigation will commence immediately and culminate in a report to the Secretary of Defense.’

He wrote that ‘information identifying a party responsible for an unauthorized disclosure’ would be referred for criminal prosecution. 

This post appeared first on FOX NEWS

previous post
RFK Jr attributes rise in autism to environmental factors, while CDC points to improved diagnostic practices
next post
Grassley, Johnson press DOJ IG to respond on whether ‘untasked’ undercover agents were present on Jan 6

Related Posts

Trump remains committed to US owning Gaza, says...

February 10, 2025

Trump quietly signs sweeping $901B defense bill after...

December 19, 2025

Biden doctor pleads the Fifth in speedy House...

July 10, 2025

‘Totally prepared’: Trump allies say he’s better positioned...

January 23, 2025

WATCH: GOP senators divided over whether Epstein documents...

August 9, 2025

Slain Hamas hostage’s family fights for the release...

April 9, 2025

New Epstein documents include photos of Bill Clinton...

December 20, 2025

MIKE PENCE: No place for antisemitism in America...

November 21, 2025

Nancy Mace’s bid to censure fellow GOP Rep....

November 20, 2025

US, Panama ‘taking back’ canal from ‘China’s influence,’...

April 9, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 3

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 4

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved